142 related articles for article (PubMed ID: 12630657)
1. Three- to four-year follow-up to an open trial of nefazodone for combat-related posttraumatic stress disorder.
Hertzberg MA; Feldman ME; Beckham JC; Moore SD; Davidson JR
Ann Clin Psychiatry; 2002 Dec; 14(4):215-21. PubMed ID: 12630657
[TBL] [Abstract][Full Text] [Related]
2. Open trial of nefazodone for combat-related posttraumatic stress disorder.
Hertzberg MA; Feldman ME; Beckham JC; Moore SD; Davidson JR
J Clin Psychiatry; 1998 Sep; 59(9):460-4. PubMed ID: 9771816
[TBL] [Abstract][Full Text] [Related]
3. Nefazodone treatment for chronic posttraumatic stress disorder: an open trial.
Davis LL; Nugent AL; Murray J; Kramer GL; Petty F
J Clin Psychopharmacol; 2000 Apr; 20(2):159-64. PubMed ID: 10770453
[TBL] [Abstract][Full Text] [Related]
4. Nefazodone in patients with treatment-refractory posttraumatic stress disorder.
Zisook S; Chentsova-Dutton YE; Smith-Vaniz A; Kline NA; Ellenor GL; Kodsi AB; Gillin JC
J Clin Psychiatry; 2000 Mar; 61(3):203-8. PubMed ID: 10817106
[TBL] [Abstract][Full Text] [Related]
5. An open-label, 12-week clinical and sleep EEG study of nefazodone in chronic combat-related posttraumatic stress disorder.
Gillin JC; Smith-Vaniz A; Schnierow B; Rapaport MH; Kelsoe J; Raimo E; Marler MR; Goyette LM; Stein MB; Zisook S
J Clin Psychiatry; 2001 Oct; 62(10):789-96. PubMed ID: 11816868
[TBL] [Abstract][Full Text] [Related]
6. Open trial of nefazodone for combat veterans with posttraumatic stress disorder.
Garfield DA; Fichtner CG; Leveroni C; Mahableshwarkar A
J Trauma Stress; 2001 Jul; 14(3):453-60. PubMed ID: 11534877
[TBL] [Abstract][Full Text] [Related]
7. The effect of nefazodone on subjective and objective sleep quality in posttraumatic stress disorder.
Neylan TC; Lenoci M; Maglione ML; Rosenlicht NZ; Leykin Y; Metzler TJ; Schoenfeld FB; Marmar CR
J Clin Psychiatry; 2003 Apr; 64(4):445-50. PubMed ID: 12716248
[TBL] [Abstract][Full Text] [Related]
8. A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study.
Davis LL; Jewell ME; Ambrose S; Farley J; English B; Bartolucci A; Petty F
J Clin Psychopharmacol; 2004 Jun; 24(3):291-7. PubMed ID: 15118483
[TBL] [Abstract][Full Text] [Related]
9. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.
Gillin JC; Rapaport M; Erman MK; Winokur A; Albala BJ
J Clin Psychiatry; 1997 May; 58(5):185-92. PubMed ID: 9184611
[TBL] [Abstract][Full Text] [Related]
10. The effects of psychotherapy, nefazodone, and their combination on subjective assessment of disturbed sleep in chronic depression.
Manber R; Rush AJ; Thase ME; Amow B; Klein D; Trivedi MH; Korenstein SG; Markowitz JC; Dunner DL; Munsaka M; Borian FE; Martin ; Keller B
Sleep; 2003 Mar; 26(2):130-6. PubMed ID: 12683470
[TBL] [Abstract][Full Text] [Related]
11. Treatment of posttraumatic stress disorder with nefazodone.
Davidson JR; Weisler RH; Malik ML; Connor KM
Int Clin Psychopharmacol; 1998 May; 13(3):111-3. PubMed ID: 9690977
[TBL] [Abstract][Full Text] [Related]
12. Bupropion treatment in veterans with posttraumatic stress disorder: an open study.
Cañive JM; Clark RD; Calais LA; Qualls C; Tuason VB
J Clin Psychopharmacol; 1998 Oct; 18(5):379-83. PubMed ID: 9790155
[TBL] [Abstract][Full Text] [Related]
13. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder.
McRae AL; Brady KT; Mellman TA; Sonne SC; Killeen TK; Timmerman MA; Bayles-Dazet W
Depress Anxiety; 2004; 19(3):190-6. PubMed ID: 15129422
[TBL] [Abstract][Full Text] [Related]
14. Nefazodone in post-traumatic stress disorder: results from six open-label trials.
Hidalgo R; Hertzberg MA; Mellman T; Petty F; Tucker P; Weisler R; Zisook S; Chen S; Churchill E; Davidson J
Int Clin Psychopharmacol; 1999 Mar; 14(2):61-8. PubMed ID: 10220119
[TBL] [Abstract][Full Text] [Related]
15. Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression.
Gelenberg AJ; Trivedi MH; Rush AJ; Thase ME; Howland R; Klein DN; Kornstein SG; Dunner DL; Markowitz JC; Hirschfeld RM; Keitner GI; Zajecka J; Kocsis JH; Russell JM; Miller I; Manber R; Arnow B; Rothbaum B; Munsaka M; Banks P; Borian FE; Keller MB
Biol Psychiatry; 2003 Oct; 54(8):806-17. PubMed ID: 14550680
[TBL] [Abstract][Full Text] [Related]
16. Open trial of nefazodone among Hispanics with major depression: efficacy, tolerability, and adherence issues.
Sánchez-Lacay JA; Lewis-Fernández R; Goetz D; Blanco C; Salmán E; Davies S; Liebowitz M
Depress Anxiety; 2001; 13(3):118-24. PubMed ID: 11387731
[TBL] [Abstract][Full Text] [Related]
17. Nefazodone treatment of major depression in alcohol-dependent patients: a double-blind, placebo-controlled trial.
Roy-Byrne PP; Pages KP; Russo JE; Jaffe C; Blume AW; Kingsley E; Cowley DS; Ries RK
J Clin Psychopharmacol; 2000 Apr; 20(2):129-36. PubMed ID: 10770449
[TBL] [Abstract][Full Text] [Related]
18. Nefazodone in major depression: adjunctive benzodiazepine therapy and tolerability.
Rickels K; Schweizer E; Case WG; DeMartinis N; Greenblatt DJ; Mandos LA; Garcia España FG
J Clin Psychopharmacol; 1998 Apr; 18(2):145-53. PubMed ID: 9580369
[TBL] [Abstract][Full Text] [Related]
19. Nefazodone therapy in patients with treatment-resistant or treatment-intolerant depression and high psychiatric comorbidity.
Sajatovic M; DiGiovanni S; Fuller M; Belton J; DeVega E; Marqua S; Liebling D
Clin Ther; 1999 Apr; 21(4):733-40. PubMed ID: 10363738
[TBL] [Abstract][Full Text] [Related]
20. An open-label study of nefazodone treatment of major depression in patients with congestive heart failure.
Lespérance F; Frasure-Smith N; Laliberté MA; White M; Lafontaine S; Calderone A; Talajic M; Rouleau JL
Can J Psychiatry; 2003 Nov; 48(10):695-701. PubMed ID: 14674053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
